120 related articles for article (PubMed ID: 1617859)
1. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
Watling SM; Kisor DF
Ann Pharmacother; 1993 Feb; 27(2):151-4. PubMed ID: 8439687
[TBL] [Abstract][Full Text] [Related]
3. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
4. Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients.
Gilman TM; Brunnemann SR; Segal JL
Antimicrob Agents Chemother; 1993 Jan; 37(1):93-9. PubMed ID: 8431022
[TBL] [Abstract][Full Text] [Related]
5. Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.
Terziivanov D; Bozhinova K; Dimitrova V; Atanasova I
Clin Pharmacokinet; 2003; 42(15):1393-409. PubMed ID: 14674790
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm.
Debord J; Pessis C; Voultoury JC; Marquet P; Lotfi H; Merle L; Lachâtre G
Fundam Clin Pharmacol; 1995; 9(1):57-61. PubMed ID: 7768489
[TBL] [Abstract][Full Text] [Related]
7. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy.
Vinks AA; Mouton JW; Touw DJ; Heijerman HG; Danhof M; Bakker W
Antimicrob Agents Chemother; 1996 May; 40(5):1091-7. PubMed ID: 8723446
[TBL] [Abstract][Full Text] [Related]
9. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Vercaigne LM; Ariano RE; Zacharias JM
Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm.
Touw DJ; Vinks AA; Neef C
Pharm World Sci; 1997 Jun; 19(3):142-51. PubMed ID: 9259030
[TBL] [Abstract][Full Text] [Related]
11. A Nonparametric Alternative to Modeling Population Pharmacokinetics in Patients with Spinal Cord Injury: Comparison with the Standard Two-Stage Method.
Segal JL; Gilman TM; Brunnemann SR
Am J Ther; 1995 Feb; 2(2):100-105. PubMed ID: 11847535
[TBL] [Abstract][Full Text] [Related]
12. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of fentanyl in healthy volunteers.
Ariano RE; Duke PC; Sitar DS
J Clin Pharmacol; 2001 Jul; 41(7):757-63. PubMed ID: 11452708
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm.
Debord J; Charmes JP; Marquet P; Merle L; Lachâtre G
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):24-7. PubMed ID: 9021438
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of six gentamicin nomograms using a bayesian parameter estimation program.
Thomson AH; Campbell KC; Kelman AW
Ther Drug Monit; 1990 May; 12(3):258-63. PubMed ID: 2349609
[TBL] [Abstract][Full Text] [Related]
17. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
[TBL] [Abstract][Full Text] [Related]
18. [Bayesian prediction of chloramphenicol blood levels in children with sepsis and malnutrition].
Lares-Asseff I; Lugo-Goytia G; Pérez-Guillé MG; Pérez Ortíz B; Guillé-Pérez A; Juárez-Olguín H; Flores-Pérez J; Santiago P; Morlán M
Rev Invest Clin; 1999; 51(3):159-65. PubMed ID: 10466006
[TBL] [Abstract][Full Text] [Related]
19. Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in children.
Patoux A; Bleyzac N; Boddy AV; Doz F; Rubie H; Bastian G; Maire P; Canal P; Chatelut E
Eur J Clin Pharmacol; 2001 Jul; 57(4):297-303. PubMed ID: 11549207
[TBL] [Abstract][Full Text] [Related]
20. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
